These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8085253

  • 1. SC-49992--a potent and specific inhibitor of platelet aggregation.
    Nicholson NS, Panzer-Knodle SG, King LW, Taite BB, Keller BT, Tjoeng FS, Engleman VW, Giorgio TD, Feigen LP.
    Thromb Res; 1994 Jun 01; 74(5):523-35. PubMed ID: 8085253
    [Abstract] [Full Text] [Related]

  • 2. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    Nicholson NS, Panzer-Knodle SG, Salyers AK, Taite BB, King LW, Miyano M, Gorczynski RJ, Williams MH, Zupec ME, Tjoeng FS.
    J Pharmacol Exp Ther; 1991 Mar 01; 256(3):876-82. PubMed ID: 2005585
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D, Lider O, Dardik R, Shenkman B, Alon R, Hershkoviz R, Kapustina G, Savion N, Martinowitz U, Greenspoon N.
    Thromb Haemost; 1993 Dec 20; 70(6):1030-6. PubMed ID: 8165596
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF, Liu CZ, Ouyang CH, Teng CM.
    Biochem Pharmacol; 1991 Aug 22; 42(6):1209-19. PubMed ID: 1888330
    [Abstract] [Full Text] [Related]

  • 12. Species variation in the effect of glycoprotein IIb/IIIa antagonists on inhibition of platelet aggregation.
    Panzer-Knodle S, Taite BB, Mehrotra DV, Nicholson NS, Feigen LP.
    J Pharmacol Toxicol Methods; 1993 Sep 22; 30(1):47-53. PubMed ID: 8241546
    [Abstract] [Full Text] [Related]

  • 13. Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs.
    Foster MR, Hornby EJ, Brown S, Kitchin J, Hann M, Ward P.
    Thromb Res; 1993 Nov 01; 72(3):231-45. PubMed ID: 8303662
    [Abstract] [Full Text] [Related]

  • 14. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
    Samanen J, Ali F, Romoff T, Calvo R, Sorenson E, Vasko J, Storer B, Berry D, Bennett D, Strohsacker M.
    J Med Chem; 1991 Oct 01; 34(10):3114-25. PubMed ID: 1920361
    [Abstract] [Full Text] [Related]

  • 15. Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.
    Sugihara H, Fukushi H, Miyawaki T, Imai Y, Terashita Z, Kawamura M, Fujisawa Y, Kita S.
    J Med Chem; 1998 Feb 12; 41(4):489-502. PubMed ID: 9484499
    [Abstract] [Full Text] [Related]

  • 16. Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications.
    Andronati SA, Karaseva TL, Krysko AA.
    Curr Med Chem; 2004 May 12; 11(9):1183-211. PubMed ID: 15134514
    [Abstract] [Full Text] [Related]

  • 17. New RGD analogue inhibits human platelet adhesion and aggregation and eliminates platelet deposition on canine vascular grafts.
    Rubin BG, McGraw DJ, Sicard GA, Santoro SA.
    J Vasc Surg; 1992 Apr 12; 15(4):683-91; discussion 691-2. PubMed ID: 1560559
    [Abstract] [Full Text] [Related]

  • 18. The in vitro and in vivo pharmacological profiles of a platelet glycoprotein IIb/IIIa antagonist, NSL-9403.
    Katada J, Takiguchi Y, Muramatsu M, Fujiyoshi T, Uno I.
    Thromb Res; 1997 Oct 01; 88(1):27-40. PubMed ID: 9336871
    [Abstract] [Full Text] [Related]

  • 19. Potent inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Asp-carboxylate of RGDX mimetics and the platelet GP IIb-IIIa receptor.
    Zablocki JA, Miyano M, Rao SN, Panzer-Knodle S, Nicholson N, Feigen L.
    J Med Chem; 1992 Dec 25; 35(26):4914-7. PubMed ID: 1479591
    [No Abstract] [Full Text] [Related]

  • 20. Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregation.
    Fok KF, Panzer-Knodle SG, Nicholson NS, Tjoeng FS, Feigen LP, Adams SP.
    Int J Pept Protein Res; 1991 Aug 25; 38(2):124-30. PubMed ID: 1783488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.